Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tamoxifen effects on endometrium.

N Colacurci1, L De Seta, P De Franciscis

  • 1Institute of Obstetrics and Gynaecology, Second University of Naples School of Medicine, Italy. def69dot@hotmail.com

Panminerva Medica
|October 6, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Maternal first trimester SIMPLE nutritional score and intrauterine fetal growth trajectory: a prospective multicentre Italian study (SIMPLE study).

The British journal of nutrition·2026
Same author

Clinical outcomes of drug-coated balloon vs. second-generation drug-eluting stent for coronary in-stent restenosis.

Clinical research in cardiology : official journal of the German Cardiac Society·2025
Same author

Multimodality imaging for cardiac amyloidosis: clinical applications and future directions.

European journal of internal medicine·2025
Same author

Reproductive outcome after frozen embryo transfer with hormone replacement therapy according to luteal-phase support protocol: systematic review and network meta-analysis of randomized controlled trials.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2025
Same author

Osteoradionecrosis incidence in pre-radiation teeth extractions: A prospective study.

Oral diseases·2024
Same author

Fertility-Sparing Treatment for Early-Stage Cervical Cancer ≥ 2 cm: Can One Still Effectively Become a Mother? A Systematic Review of Fertility Outcomes.

Annals of surgical oncology·2023
Same journal

Circulating osteopontin and body composition in systemic lupus erythematosus: a cross-sectional study.

Panminerva medica·2026
Same journal

Fluid de-resuscitation in critical illness: are we measuring the right endpoint?

Panminerva medica·2026
Same journal

A standardized Ferula supplement (Menotrack) to prevent symptoms in post-menopause: a 3-month supplement registry.

Panminerva medica·2026
Same journal

Impact of cardiogenic shock on outcomes in patients with spontaneous coronary artery dissection: a systematic review and meta-analysis.

Panminerva medica·2026
Same journal

Characteristics and outcomes of spontaneous coronary artery dissection versus Takotsubo Syndrome: a systematic review and meta-analysis.

Panminerva medica·2026
Same journal

Medical decluttering: what it is and why it is important.

Panminerva medica·2026
See all related articles

Tamoxifen treatment in postmenopausal women increases the risk of endometrial hyperplasia and cancer. Regular gynecological check-ups are crucial for early detection and management of these Tamoxifen-related endometrial changes.

Area of Science:

  • Gynecology
  • Oncology
  • Pharmacology

Background:

  • Tamoxifen is a common treatment for breast cancer in postmenopausal women.
  • Long-term effects of Tamoxifen on the endometrium require evaluation, especially in asymptomatic patients.
  • This study focuses on postmenopausal breast cancer survivors undergoing Tamoxifen therapy.

Purpose of the Study:

  • To assess the endometrial effects of long-term Tamoxifen treatment.
  • To identify potential gynecological complications associated with Tamoxifen therapy.
  • To evaluate the incidence of endometrial hyperplasia and neoplasia in patients on Tamoxifen.

Main Methods:

  • A comparative study involving 45 postmenopausal breast cancer patients on Tamoxifen (Group I) and 7 controls (Group II).

Related Experiment Videos

  • Transvaginal ultrasonography and hysteroscopy with guided biopsy were performed for all participants.
  • Endometrial tissue was analyzed for hyperplastic and neoplastic changes.

    • Main Results:

    • Abnormal endometrial thickening was observed in 35.4% of Tamoxifen-treated patients versus 14.3% in controls.
    • Endometrial hyperplasia occurred in 33.4% and polyps in 6.25% of Tamoxifen users.
    • A small percentage of Tamoxifen users (4.1%) developed endometrial cancer, while one control had an endometrial polyp.

    Conclusions:

    • Tamoxifen therapy is linked to a higher incidence of proliferative and neoplastic endometrial changes.
    • No clear correlation was found between Tamoxifen duration and endometrial pathology development.
    • Annual gynecological evaluations are essential for monitoring Tamoxifen-treated patients for endometrial abnormalities.